Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro hydroxyurea decreases Th1 cell-mediated immunity.

A Weinberg1

  • 1Department of Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA. adriana.weinberg@uchsc.edu

Clinical and Diagnostic Laboratory Immunology
|June 28, 2001
PubMed
Summary

Hydroxyurea (HU) can impair T-cell immune responses by reducing lymphocyte proliferation and gamma interferon. This effect is reversible and occurs in both HIV-infected and uninfected individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pediatric pelvic trauma].

Der Unfallchirurg·2020
Same author

Organizational uptake of NICE guidance in promoting employees' psychological health.

Occupational medicine (Oxford, England)·2018
Same author

Transcriptome analysis of Porphyromonas gingivalis and Acinetobacter baumannii in polymicrobial communities.

Molecular oral microbiology·2018
Same author

Innate immunity in HIV-1 infection: epithelial and non-specific host factors of mucosal immunity- a workshop report.

Oral diseases·2016
Same author

Transforming growth factor-β1 sustains the survival of Foxp3(+) regulatory cells during late phase of oropharyngeal candidiasis infection.

Mucosal immunology·2015
Same author

Association of Toll-like receptor polymorphisms with HIV status in North Americans.

Genes and immunity·2014

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Hydroxyurea (HU) is a medication used for hematologic disorders and sometimes in combination therapy for human immunodeficiency virus (HIV) suppression.
  • HU can exhibit toxicity towards rapidly dividing cells, including immune response effectors.

Purpose of the Study:

  • To investigate the impact of Hydroxyurea on specific T-cell responses.
  • To assess the effects of HU on lymphocyte proliferation and cytokine production.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from HIV-infected patients and healthy controls were stimulated with microbial antigen and mitogen in the presence of varying HU concentrations (10–1,000 µM).
  • Lymphocyte proliferation and cytokine production (Interferon-gamma, Interleukin-2, Interleukin-10) were measured.

Related Experiment Videos

Main Results:

  • HU significantly decreased lymphocyte proliferation and gamma interferon production in PBMCs from both HIV-infected and uninfected individuals.
  • Interleukin-2 and Interleukin-10 production remained unaffected by HU treatment.
  • The inhibitory effect of HU was dependent on continuous drug exposure and was reversible upon drug removal.

Conclusions:

  • Hydroxyurea treatment can suppress Th1-cell-mediated immune responses.
  • These findings suggest potential implications for immune function in patients receiving HU-containing therapies.